control group:SOX regimen

3 trials

Sponsors

The First Medical Center of the PLA General Hospital, Tianjin Medical University Cancer Institute & Hospital, Linyi People's Hospital

Conditions

Adenocarcinoma of the esophagogastric junctionGastric CancerGastroesophageal cancer

Phase 2

Clinical study of Pabolizumab for neoadjuvant therapy of Siewert II/III adenocarcinoma of the esophagogastric junction

RecruitingChiCTR2100046070

The First Medical Center of the PLA General HospitalAdenocarcinoma of the esophagogastric junction

Start: 2021-06-01Updated: 2021-12-13

Randomized controlled trial of peri-operative sintilimab in combination with SOX in locally advanced gastric cancer

RecruitingChiCTR2100046711

Tianjin Medical University Cancer Institute & HospitalGastric Cancer

Start: 2021-07-01Updated: 2022-01-10

Phase 4

An open-label, single-center, controlled study of fruquintinib combined with SOX regimen versus SOX regimen in the perioperative treatment of locally advanced gastroesophageal cancer

Active, not recruitingChiCTR2400083556

Linyi People's HospitalGastroesophageal cancer

Start: 2024-04-30Updated: 2024-04-29